Percutaneous Coronary Intervention with Procedural Unfractionated Heparin without Activated Clotting Time Guidance: A Unique Opportunity to Assess Thrombotic and Bleeding Events
Table 2
Procedural characteristics.
Mean (count)
Standard deviation (percentage)
Time of procedure (min)
69
33.4
Number of stents
1.6 (range = 0–7)
0.9
Diagnosis
Stable angina/stable CAD
400
55.7
NSTEMI
108
15.0
STEMI
87
12.1
Staged PCI
73
10.2
Unstable angina
50
7.0
Access site
Radial
562
78.3
Femoral
151
21.0
Ulnar
5
0.7
Antiplatelet
Glycoprotein IIb/IIIa inhibitor (IV)
33
4.6
Clopidogrel (oral)
499
69.5
Ticagrelor (oral)
192
26.7
Prasugrel (oral)
27
3.8
Oral antiplatelets preload
127
17.7
Oral antiplatelets ad hoc load
591
82.3
Lesions intervened n = 1108
LAD territory
498
69.4
RCA territory
294
40.9
LCX territory
264
36.8
Ramus intermedius
26
3.6
Left main
16
2.2
Coronary bypass graft
0
0
CAD: coronary artery disease; LAD: left anterior descending; LCX: left circumflex; NSTEMI: non-ST-segment elevation myocardial infarction; PCI: percutaneous coronary intervention; RCA: right coronary artery; STEMI: ST-segment elevation myocardial infarction.
